cluster g4 mb driver gene along human chromosome suggest reason predilection cnas snvs g4 mb also explain specific pattern genomic gain loss emphasize g4 mb disease human genome g4 mb cell appear stall developmental time release developmental blockade result resumption pseudonormal developmental differentiation cascade mb cancer human rl g4 mb probably arise embryological remnant rlsvz perls secondary otx2 overactivity cbfa complex failure propose detection perl postnatal period either image biochemical detection oncofetal antigen serum could enable closer monitor potential early intervention prevent emergence fullblown g3 g4 mb statistical method use predetermine sample size experiment randomize investigator blind allocation experiment outcome assessment except case perform immunohistochemistry ihcbased cell count investigator perform count blind experimental condition sample age antibody use sample use generate bulk rnaseq group obtain medulloblastoma advance genomics international consortium magic sample use generate scrnaseq group obtain compliance ethical regulation hospital sick child mcgill university health centre patient material collect receive inform consent approval oversight respective internal review board relevant clinical metadata overlap data type 819 primary mb sample use study present supplementary table 2. human cerebellar sample use study obtain use protocol approve seattle child 's research institute 's institutional review board sample use histological analysis collect human developmental biology resource locate university college london newcastle university unite kingdom birth defect research laboratory university washington unite state third trimester sample part archival collection h00pital neckerenfants malades paris france sample collect previous patient consent strict accordance institutional legal ethical guideline formalinfixed paraffinembedded section cerebellum collect 408m thickness along sagittal plane mount superfrost plus slide thermo fisher scientific slide refrigerate preserve antigenicity prevent rna degradation embryonic mouse tissue collect accordance guideline lay institutional animal care use committee seattle child 's research institute national institute health guideline care use laboratory animal accordance applicable portion animal welfare act mouse maintain corncob bed 1014 h darklight cycle ambient temperature humidity monitor maintain within recommend range guide care use laboratory animal 8th edition cd1 mouse cross day plug take embryonic day 0.5 e0.5 embryo male female dissect e14.5 e16.5 fix 4 paraformaldehyde 12 h wash pb transfer solution 30 sucrose overnight sample embed optimum cut temperature matrix midsagittal cryosections 11 μm thickness collect two g3 mb cell line use study hdmb03 mb3w1 hdmb03 provide t. milde describe ref mb3w1 provide m. w02lfl describe ref commonly misidentified cell line use study cell line use authenticate str profile atcc 2021. cell line test mycoplasma contamination formalinfixed paraffinembedded section deparaffinized xylene rehydrated gradient ethanol process haematoxylin eosin stain carry previously describe ihc perform previously describe follow primary antibody use ki67 agilent m7240 mouse 1:50 thermo fisher ma514520 rabbit 1:100 sox2 thermo fisher pa1094 rabbit 1:200 pax6 biolegend 901301 rabbit 1:300 tbr2 eomes thermo fisher 14487582 rat 1:200 gfap agilent z0334 rabbit 1:1,000. fluorescentdyelabelled secondary antibody thermo fisher use dilution 1:1,000 antirabbit alexa fluor 488 a11034 goat alexa fluor 568 a11011 goat antimouse alexa fluor 488 a11001 goat alexa fluor 568 a11004 goat secondary antibody incubation section counterstained dapi 4',6diamidino2phenylindole use vectashield mount medium vector laboratory h1200 situ hybridization assay run use commercially available probe advance cell diagnostics manufacturerrecommended protocol use without modification follow probe use study lmx1a 540661 otx2 484581 cbfa2t2 410331 cbfa2t3 406001 mki67 591771 hbegf 431651 cbfa2t2 491601 cbfa2t3 434601 hbegf 437601. section counterstained haematoxylin methyl green slide fluorescence immunohistochemical assay image use zeiss lsmmeta confocal microscope zen 2009 software zeiss nanozoomer digital pathology slide scanner hamamatsu use brightfield microscopy bar minor adjustment contrast brightness additional image alteration perform figure prepare use adobe illustrator cell count manually perform use imagej count minimum three section three sample use ki67 pax6 tbr2 eomes count total number ki67 tbr2 eomes pax6 cell relative total dapi count rl determine 3×haturboidnlspcdna3 gift a. ting addgene plasmid 107171. pcmv6accbfa2t2gfp purchase origene rg202013 pcramplified turboid cbfa2t2 cod sequence introduce kpniclailinearized pcagh2bmagp2a vector use nebuilder hifi assembly new england biolabs nonvector sequence resultant plasmid pcagh2bmagp2a3×haturboidcbfa2t2 pcagh2bmagp2a3×haturboid verify sanger sequence turboid experiment 3 × 10 hdmb03 cell seed equally across 6well ultralow attachment plate transfected 12 μg plasmid use lipofectamine 3000 thermo fisher accord manufacturer 's guideline cell grow suspension 72 h stempro nsc serumfree medium life technology 72 h incubation biotind sigma b4639 add well final concentration 500 μm cell incubate 15 min tumourspheres collect wash 1×pbs snapfrozen store 80 °c run complete replicate sample thaw ice lysed 1 ml 1× ripa 20 mm trishcl ph 7.5 150 mm nacl 1 mm edtana 1 mm egta 1 np40 1 sodium deoxycholate 2.5 mm sodium pyrophosphate 1 mm βglycerophosphate 1 mm navo 1× halt proteasephosphatase inhibitor thermoscientific 10 min sample sonicated twice 10 pulse 30 load shear dna fisher scientific sonicator fb50 microprobe lysed sample clarify centrifugation 16,000g 10 min 4 °c supernatant quantify use bradford protein assay follow quantification 50 08l aliquot streptavidinsepharose bead slurry sample wash 1 ml 1× ripa wash bead aliquot resuspend 1 ml 1× ripa contain 2 mg quantify protein supernatant rotate overnight 4 °c sample centrifuge 1,000g 5 min bead pellet wash twice 1 ml 2 sd solution doubledistilled ho follow three wash 1 ml wash buffer 50 mm trishcl ph 7.4 8 urea rotate 8 min room temperature time sample resuspend storage buffer 285 μl ammonium bicarbonate 50 mm 15 μl 1 mm biotin saturate streptavidin bind prevent peptide recapture onbead digestion sample store ice analysis mass spectrometry m data obtain orbitrap exploris 480 instrument thermo fisher scientific analysis perform manitoba centre proteomics system biology m raw file process proteome discoverer v.2.20.388 search tryptic peptide human uniprot protein database date access december 2020 use sequest follow standard orbitrap set 2 miss cleavage permit parent fragment mass tolerance 0.02 da 15 ppm respectively fix modification cysteine carbamidomethylation apply variable modification include aminoterminal acetylation deamidation n q phosphorylation oxidation w ubiquitylation k double oxidation w biotinylation k permit result filter 1 false discovery rate fdr protein peptide level saintexpress v.1.0.0 use calculate probability potential proximal protein interaction background contaminant use default parameter three replicate use control experimental sample full list cbfa2t2interacting protein find supplementary table 3. otx2kd hdmb03 mb3w1 g3 mb cell 2 × 10 cell per well perform previously describe brief otx2 silence use 30 nm silencer select sirnas 9931 9932 life technology nonsilencing scramble serve negative control bulk rnaseq otx2 knock three independent biological replicate cell line silence confirm western blot otx2 abcam ab21990 rabbit 1:500 βactin sigmaaldrich a2228 mouse 1:1,000 use load control 72 h follow transfection total rna extract sample use norgen rna extraction kit norgen biotek bulk rnaseq perform stemcore laboratory ottawa hospital research institute snrnaseq repeat 4.5 × 10 cell per well mb3w1 use one replicate perform gn differentiation validate western blot rbfox3 neun cell signal technology d4g4o 1:1,000. hdmb03 g3 mb cell plat density 2 × 10 cell per well 6well format 24 h infection follow day precision lentiorf cbfa2t2 viral particle ohs5898219582524 rfp control lentiviral particle horizon discovery bioscience add cell optimem life technology multiplicity infection 1. twentyfour hour infection optimem aspirate replace emem10 fbs positively transduce cell stably select blasticidin start day 5. increase cbfa2t2 expression confirm quantitative pcr immunoblotting cbfa2t2 a303593am bethyl laboratory 1:500 βactin sigmaaldrich a2228 mouse 1:1,000 use load control follow stable selection cell expansion assessment total cell number viability perform previously describe brief hdmb03 rfp control cbfa2t2 overexpression cell dissociate culture tumourspheres 6well ultralow attachment plate density 2 × 10 cell per well triplicate stempro nsc serumfree medium life technology total number cell count day 5 viability assess trypan blue exclusion mri scan perform patient mb hospital sick child canada tumour subsequently subgrouped methylation array cbfa2t2 mutation validate sanger sequence data show brief nest pcr perform use follow reagent master mix 2.5 08l 10× pcr buffer invitrogen 52724 1 08l 50 mm mgcl invitrogen 52723 0.5 08l 10mm dntp bio basic dd0056 0.5 08l f primer 0.5 08l r primer 2 08l load dye 0.2 08l taq polymerase invitrogen 100021278 15.8 08l ddho wisent 809115cl 2 08l dna secondary pcr product run 2 agarose gel tae buffer confirm expect product size mutation band excise clean geneaid pcr cleanup kit geneaid dfc100 sanger sequence addition ta clone mutation use ta clone kit thermo fisher 450641 follow mini prep geneaid presto mini plasmid kit geneaid pd100 sanger sequence sample process sequence previously describe hs37d5 reference genome fasta 1000 genome project phase ii append c12 ercc spikein sequence use c1 fluidigm well caltech profile 3 spikeins sequence encode star assembly build reference gencode v.19 gene annotation use follow parameter sjdboverhang 124. rnaseq library read map build assembly use star v.2.5.1b follow parameter outfiltermultimapnmax 20 alignsjoverhangmin 8 alignmatesgapmax 200000 alignintronmax 200000 alignsjdboverhangmin 10 alignsjstitchmismatchnmax 5 1 5 5 outsammultnmax 20 twopassmode basic alignment otx2kd g3 cell line raw sequence data process fastp v.0.20.1 perform automatic adapter trim readquality filter retain read least 60 base q ≥ 15 5 'n base transcript scramble otx2kd sample quantify use salmon v.1.4.0 index build gencode v.35 reference assembly inclusion genomic decoy sequence subtypes determine use similarity network fusion snf previously describe use rnaseq expression data place microarray expression data brief full expression methylation matrix input snf function r package snftool v.2.3.0 follow parameter k 20 α 0.5 100. spectral cluster perform cluster obtain k 6 correspond 6 g3 g4 subtypes differential expression analysis perform use r package deseq2 v.1.28.1 compare subtype five control subgroup covariate gene fdr adjust p value 0.05 consider downstream analysis full list subtypespecific differentially express gene find supplementary table 4. rnaseq mutation call perform previously describe brief gatk v.3.8.0 use detect variant annotate annovar february 2016. snp present gnomad database discard snp frequency greater 0.01 1000 genome dnsnp138 radar exome aggregation consortium database nhlbiesp project kaviar genomic variant database haplotype reference consortium database greater middle east variome brazilian genomic variant database inhouse snp database 356 sequence whole genome discard significantly mutate gene q 0.05 identify use mutsigcv v.1.41 oncodrivefml v.2.3.0 full list mutation detect g3 g4 mb find supplementary table 5. gene fusion call filter previously describe brief three fusion call algorithm run maximize sensitivity starfusion v.0.8.0 infusion v.0.7.3 transabyss v.2.0.0 putative fusion call least two algorithm detect normal occur know mutate gene retain sample preprocessed previously describe process snp6 segment file input gistic 2.0 v.2.0.23 run follow change default parameter conf 0.90 broad 1 ta 0.25 td 0.3 j 10 rx 0 brlen 0.7 armpeel 1 gcm extreme genegistic significantly amplify delete region extract manually inspect igv categorize either broad focal event depend whether segment span 12 mb ≤12 mb respectively determine whether gene fall significantly amplify delete region show concomitant expression change gene expression categorize applicable amplification neutral loss kruskalwallis test perform greater two condition whereas mannwhitney utest perform case two condition significance adjust use posthoc dunn 's test benjaminihochberg correction patient sample tumour collect time surgical resection tumour tissue mechanically dissociate follow collagenasebased enzymatic dissociation previously describe singlecell suspension assess trypan blue count aim load 10,00015,000 cell per sample use chromium controller combination chromium single cell 3 v3 v3.1 gel bead chip kit 10x genomics individual cell partition gel beadsinemulsion follow reverse transcription barcoded rna cdna amplification individual singlecell library index illumina p5p7 adapter generate use chromium single cell 3 library kit chromium multiplex kit library sequence illumina novaseq6000 sequencer genelevel count obtain use 10x cellranger pipeline v.3.1.0 brief raw base call file demultiplexed fastqs use mkfastq function fastq file align reference human genome hg19 v.3.0.0 10x genomics use count function generate raw genebarcode count matrix alignment quality control metric scrnaseq snrnaseq sample find supplementary table 6. quality control perform individual sample level sample integration normalization brief lowquality cell determine exclude analysis base outlier mitochondrial content indicative cellular stress damage gene count use r package seurat v.4.0.2 gene express fewer ten cell also remove highquality cell tumour sample merge normalize together use sctransform v.0.3.2 use parameter variable.features.n 3,000 regress unwanted variance associate mitochondrial content singlecell cluster perform first use principal component analysis determine statistically significant principal component use construct uniform manifold approximation projection umap embed seurat v.4.0.2 cell cluster identify use seurat 's sharednearest neighbour algorithm follow modularity optimization use louvain algorithm multilevel refinement nontumour cell type present tumour singlecell sample first identify examine expression know celltypespecific marker extend data fig 7g expect cluster display overlap different sample confirm remain samplespecific cell cluster compost tumour cell infercnv v.1.4.0 use use nontumour cell reference use follow parameter hmmtype i6 noisefilter 0.1 cutoff 0.1 sdamplifier 0.15 extend data fig 7e tumour cell cluster confirm cnvs characteristic subgroup one sample shh mb3862 detect cnvs extend data fig 7f give high proportion tumour cell shh mb sample compare nontumour microenvironment cell distinct cluster microenvironment cell label tumour cell identify putative ligandreceptor interaction occur tumour cell microenvironmental nontumour cell scrnaseq data use ccinx v.0.4 previously describe brief scale expression level subgroupspecific ligand microglia receptor g4 mb tumour cell calculate use function buildgenestatlist interaction determine use builtin curated database ligandreceptor interaction \<SEP>0